AIM-LO: Non-HDL Cholesterol: Evolving Evidence Leads to a Novel Strategy

You must be logged in to view this media.

Log in or Register

03:31

AIM-LO: Non-HDL Cholesterol: Evolving Evidence Leads to a Novel Strategy

Broadcast Date
Presenter
Eva Lonn, MD, MSc, FRCPC, FACC
Therapeutic Area
Cardiovascular

Dr. Eva Lonn explains why non-HDL cholesterol is now defined as the preferred measurement over LDL-C, particularly for patients with elevated triglycerides, in the 2021 CCS Dyslipidemia guidelines.

Handout: Non-HDL Cholesterol 

Video Transcript